EMA Fellows to Study Japanese Drug Regulation
Drug regulators in the European Union and Japan have set up a fellowship program to foster collaboration, share information and improve regulation, Japan’s Pharmaceuticals and Medical Devices Agency announced.
Under the program, representatives from the European Medicines Agency will spend two to three weeks in Japan working on various projects. The first visitors will look at procedures for drug assessment, from pre-market to post-market, Oct. 12-27, PMDA said.
The EMA emissaries will meet with staff at PMDA and the Ministry of Health, Labour and Welfare and with other stakeholders.